Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 2Lung Neoplasms 2Thymus Neoplasms 1Small Cell Lung Carcinoma 1Retinoblastoma 1Pancreatic Neoplasms 1Neoplasms 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Gliosarcoma 1Glioblastoma 1Eye Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoid Tumor 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Proton Therapy × Clear all
NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡